PANORAMA ACTUEL DES MEDICAMENTS HYPOLIPEMIANTSHELLER F; HARVENGT C.1980; BULL. SOC. PHARM. LILLE; ISSN 0366-3507; FRA; DA. 1980; VOL. 36; NO 3-4; PP. 209-219; BIBL. 3 P.Article

RECIPROCAL RESPONSES TO CLOFIBRATE IN KETOGENESIS AND TRIGLYCERIDE AND CHOLESTEROL SECRETION IN ISOLATED RAT LIVERIDE T; OKU H; SUGANO M et al.1982; METABOLISM, CLINICAL AND EXPERIMENTAL; ISSN 0026-0495; USA; DA. 1982; VOL. 31; NO 10; PP. 1065-1072; BIBL. 61 REF.Article

POTENTIAL HYPOLIPIDEMIC AGENTS. IV. PREPARATION OF 4 NEW 5,6-DIHALONICOTINIC ACIDSGACEK M; GRONOWITZ S; HEDBOM C et al.1972; ACTA PHARM. SUECICA; SUEDE; DA. 1972; VOL. 9; NO 4; PP. 373-376; BIBL. 10REF.Serial Issue

PEROXISOME PROLIFERATION IN CULTURED RAT HEPATOCYTES PRODUCED BY CLOFIBRATE AND PHTHALATE ESTER METABOLITESGRAY TJB; BEAMAND JA; LAKE BG et al.1982; TOXICOL. LETT.; ISSN 0378-4274; NLD; DA. 1982; VOL. 10; NO 2-3; PP. 273-279; BIBL. 16 REF.Article

LES MEDICAMENTS HYPOLIPIDEMIANTSBONTE JP; BERTHELOT P.1980; BULL. SOC. PHARM. LILLE; ISSN 0366-3507; FRA; DA. 1980; VOL. 36; NO 3-4; PP. 243-262; BIBL. 2 P.Article

EFFECTS OF CLOFIBRATE ON SOME MICROSOMAL HYDROXYLATIONS INVOLVED IN THE FORMATION AND METABOLISM OF BILE ACIDS IN RAT LIVERANGELIN B; BJORKHEM I; EINARSSON K et al.1976; BIOCHEM. J.; G.B.; DA. 1976; VOL. 156; NO 2; PP. 445-448; BIBL. 31 REF.Article

2.111.702 (B) (7137418). - 19OCTOBRE1971. NOUVEAUX DERIVES DE L'INDOLINE, LEUR PREPARATION ET MEDICAMENTS CONTENANT CES DERIVESsdPatent

2.115.358 (B) (7141922). - 23NOVEMBRE 1971. COMPOSITION PHARMACEUTIQUE CONTENANT UN DERIVE D'ACIDE NICOTINIQUEsdPatent

HYPOLIPIDAEMIC AGENTSHOWE R.1974; ADV. DRUG RES.; U.S.A.; DA. 1974; VOL. 9; PP. 7-39; BIBL. 5 P. 1/2Article

AZIONE DI UN NUOVO COMPLESSO ENZIMATICO AD AZIONE ELASTOLITICA NELL'ATEROSCLEROSI CLINICA = ACTION D'UN NOUVEAU COMPLEXE ENZYMATIQUE A ACTION ELASTOLYTIQUE DANS L'ATHEROSCLEROSE CLINIQUEPRETOLANI E; COCCHERI S; DE ROSA V et al.1972; BOLL. SOC. ITAL. BIOL. SPER.; ITAL.; DA. 1972; VOL. 48; NO 7; PP. 174-176; BIBL. 1REF.Serial Issue

2.115.359 (B) (7141923). - 23NOVEMBRE 1971. DERIVES DE L'ACIDE NICOTINIQUEsdPatent

2.126.314 (B) (7206012). - 23 FEVRIER 1972. NOUVEAUX DERIVES DE LA P-PHENYLENE-DIAMINE, LEUR PREPARATION ET LEUR APPLICATION COMME MEDICAMENTSsdPatent

BEZAFIBRATE DOES NOT INFLUENCE THE QT INTERVAL IN MANOLSSON AG; EKELUND LG; LANG PD et al.1983; JOURNAL OF CARDIOVASCULAR PHARMACOLOGY; ISSN 0160-2446; USA; DA. 1983; VOL. 5; NO 2; PP. 341-342; BIBL. 6 REF.Article

GEMFIBROZIL IN THE TREATMENT OF DYSLIPIDAEMIA. A 5-YEAR FOLOOW-UP STUDYMANNINEN V; MALKONEN M; EISALO A et al.1982; ACTA MEDICA SCANDINAVICA. SUPPLEMENTUM; ISSN 0365-463X; SWE; DA. 1982; NO 668; PP. 82-87; BIBL. 22 REF.Article

METABOLIC DISEASES AND ENDOCRINE FUNCTIONBAILEY DM.1980; ANNU. REP. MED. CHEM.; ISSN 0065-7743; USA; DA. 1980; VOL. 15; PP. 162-206; BIBL. DISSEM.Article

NACH DEM CLOFIBRAT-VERBOT VERFUEGBARE LIPIDSENKER. KLINISCH-PHARMAKOLOGISCHE SICHTUNG = SELECTION DES HYPOLIPEMIANTS APRES LE VERDICT DU CLOFIBRATE. POINTS DE VUE CLINIQUES ET PHARMACOLOGIQUESMERTZ DP.1979; FORTSCHR. D. MED.; DEU; DA. 1979; VOL. 97; NO 15; PP. 695-698; ABS. ENG; BIBL. 24 REF.Article

HYPOCHOLESTEROLEMIC EFFECTS OF CHITOSAN IN CHOLESTEROL-FED RATSSUGANO M; FUJIKAWA T; HITATSUJI Y et al.1978; NUTRIT. REP. INTERNATION.; USA; DA. 1978; VOL. 18; NO 5; PP. 531-537; BIBL. 19 REF.Article

TOLERANCE HEPATIQUE DU PROCETOFENEROSSI A.1978; NOUV. PRESSE MED.; FRA; DA. 1978; VOL. 7; NO 35; PP. 3153Article

A REAPPRAISAL OF THE MECHANISMS OF HYPOCHOLESTEROLEMIC ACTION OF THERAPEUTIC AGENTSSODHI HS; KUDCHODKAR BJ; CLIFFORD C et al.1978; ADV. EXPER. MED. BIOL.; USA; DA. 1978; VOL. 109; PP. 331-345; BIBL. 33 REF.Conference Paper

CHOLESTYRAMINE TREATMENT OF PSEUDOMEMBRANOUS COLITISSINATRA F; BUNTAIN WL; MITCHELL CH et al.1976; J. PEDIATR.; U.S.A.; DA. 1976; VOL. 88; NO 2; PP. 304-306; BIBL. 7 REF.Article

FUNCTIONAL CHANGE IN HEPATIC MITOCHONDRIA OF SWINE FED ETHYLCHLOROPHENOXYISOBUTYRATE = MODIFICATION FONCTIONNELLE DANS LES MITOCHONDRIES HEPATIQUES DU PORC NOURRI AVEC DU CHLOROPHENOXYISOBUTYRATE D'ETHYLEMORRISON ES; SOOK KYUNG LEE; SCOTT RF et al.1976; TOXICOL. APPL. PHARMACOL.; U.S.A.; DA. 1976; VOL. 36; NO 1; PP. 99-110; BIBL. 26 REF.Article

A NICOTINIC ACID ESTER AND EXPERIMENTAL ATHEROSCLEROSIS. NO SIGNIFICANT EFFECT OF TREATMENT WITH NICERITROL (PENTAERYTHRITOLTETRANICOTINATE) ON CHOLESTEROL IN AORTA OF RABBITS PREVIOUSLY FED WITH CHOLESTEROL-ENRICHED DIETSTENDER S; ASTRUP P; BRATTSAND R et al.1976; ATHEROSCLEROSIS; NETHERL.; DA. 1976; VOL. 23; NO 3; PP. 503-511; BIBL. 15 REF.Article

ANTILIPIDEMIC DRUGS. V. EVALUATION OF THE HYPOLIDEMIC EFFECT OF LF-178 IN 191 POTIENTS AFFECTED BY THE ATHEROGENIC FORM OF ENDOGENOUS HYPERLIPOPROTEINEMIA (TYPES, IIA, IIB AND IV)ROUFFY J; DREUX C; GOUSSAULT Y et al.1976; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1976; VOL. 26; NO 5; PP. 901-906; ABS. ALLEM.; BIBL. 7 REF.Article

DIAZACHOLESTEROL AND TRIPARANOL INDUCED MYOTONIA IN RATS ACHIEVED BY SINGLE DOSE ADMINISTRATION.DROMGOOLE SH; CAMPION DS; PETER JB et al.1975; EXPER. NEUROL.; U.S.A.; DA. 1975; VOL. 49; NO 1 PART. 1; PP. 327-329; BIBL. 2 REF.Article

EFFECT OF ADMINISTRATION OF CLOFIBRATE AND CLOFENAPATE ON OXIDATIVE PHOSPHORYLATION BY LIVER MITOCHONDRIA IN THE RAT.KRISHNAKANTHA TP; MOHAN VP; SUVIRA CHHABRA et al.1975; INDIAN J. BIOCHEM. BIOPHYS.; INDIA; DA. 1975; VOL. 12; NO 1; PP. 31-34; BIBL. 27 REF.Article